ANDA 87725, held by Bayer Hlthcare. Diatrizoate Sodium.
As of Nov 16, 2026, ANDA 87725 (Urovist Sodium 300), held by Bayer Hlthcare, was first approved by FDA on Sep 23, 1982, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 23, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Urovist Sodium 30050% ยท injectable;injection | Diatrizoate Sodium | Discontinued |
| Dec 28, 1995 | Supplement 6Labeling | Approved | None posted |
| Aug 23, 1989 | Supplement 5Labeling | Approved | None posted |
| Sep 23, 1982 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters